{"entity":{"type":"insider","cik":"0001397188","url":"/insider/0001397188","json_url":"/insider/0001397188.json","name":"Sofinnova Management VI, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":5,"first":"2011-12-23","last":"2016-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Sofinnova Management VI, L.L.C.","source":"filing","n_filings":5,"first_seen":"2011-12-23","last_seen":"2016-10-24"}],"transactions":[{"id":3125948,"accession":"0001144204-16-129201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-129201","line_url":"/filing/0001144204-16-129201#line-3","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VI L P; Mehra Anand; Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Sofinnova Management VI, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":724788.0,"shares_display":"724,788","price_per_share":1.389,"price_display":"1.39","price_state":"stated","total_value":1006730.532,"total_display":"1,006,730.53","total_whole":"1,006,731","shares_owned_after":1134851.0,"shares_owned_after_display":"1,134,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-24","scope":"insider"},{"id":3125946,"accession":"0001144204-16-129201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-129201","line_url":"/filing/0001144204-16-129201#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VI L P; Mehra Anand; Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Sofinnova Management VI, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13367.0,"shares_display":"13,367","price_per_share":1.389,"price_display":"1.39","price_state":"stated","total_value":18566.763,"total_display":"18,566.76","total_whole":"18,567","shares_owned_after":224845.0,"shares_owned_after_display":"224,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-24","scope":"insider"},{"id":3125942,"accession":"0001144204-16-129201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-129201","line_url":"/filing/0001144204-16-129201#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VI L P; Mehra Anand; Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Sofinnova Management VI, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12528.0,"shares_display":"12,528","price_per_share":1.389,"price_display":"1.39","price_state":"stated","total_value":17401.392,"total_display":"17,401.39","total_whole":"17,401","shares_owned_after":15470.0,"shares_owned_after_display":"15,470","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-24","scope":"insider"},{"id":6785999,"accession":"0001181431-14-028521","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-14-028521","line_url":"/filing/0001181431-14-028521#line-12","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VI, L.L.C.; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Venture Affiliates VI LP; HEALY JAMES; POWELL MICHAEL; Mehra Anand","owner_display_name":"Sofinnova Management VI, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":724788.0,"shares_display":"724,788","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":5798304.0,"total_display":"5,798,304.00","total_whole":"5,798,304","shares_owned_after":1859639.0,"shares_owned_after_display":"1,859,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":6785996,"accession":"0001181431-14-028521","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-14-028521","line_url":"/filing/0001181431-14-028521#line-11","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VI, L.L.C.; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Venture Affiliates VI LP; HEALY JAMES; POWELL MICHAEL; Mehra Anand","owner_display_name":"Sofinnova Management VI, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13367.0,"shares_display":"13,367","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":106936.0,"total_display":"106,936.00","total_whole":"106,936","shares_owned_after":238212.0,"shares_owned_after_display":"238,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":6785994,"accession":"0001181431-14-028521","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-14-028521","line_url":"/filing/0001181431-14-028521#line-10","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VI, L.L.C.; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Venture Affiliates VI LP; HEALY JAMES; POWELL MICHAEL; Mehra Anand","owner_display_name":"Sofinnova Management VI, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12528.0,"shares_display":"12,528","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":100224.0,"total_display":"100,224.00","total_whole":"100,224","shares_owned_after":27998.0,"shares_owned_after_display":"27,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":4882080,"accession":"0001181431-13-040378","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-040378","line_url":"/filing/0001181431-13-040378#line-3","is_derivative":false,"issuer_cik":"0001211465","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001211465","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":322809.0,"shares_display":"322,809","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":1945376.1576,"total_display":"1,945,376.16","total_whole":"1,945,376","shares_owned_after":1025364.0,"shares_owned_after_display":"1,025,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider"},{"id":4882076,"accession":"0001181431-13-040378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-040378","line_url":"/filing/0001181431-13-040378#line-2","is_derivative":false,"issuer_cik":"0001211465","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001211465","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63957.0,"shares_display":"63,957","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":385430.4648,"total_display":"385,430.46","total_whole":"385,430","shares_owned_after":203152.0,"shares_owned_after_display":"203,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider"},{"id":4882070,"accession":"0001181431-13-040378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-040378","line_url":"/filing/0001181431-13-040378#line-1","is_derivative":false,"issuer_cik":"0001211465","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001211465","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; Azan Alain; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Venture Partners VI GmbH & Co. KG; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4400.0,"shares_display":"4,400","price_per_share":6.0264,"price_display":"6.03","price_state":"stated","total_value":26516.16,"total_display":"26,516.16","total_whole":"26,516","shares_owned_after":13976.0,"shares_owned_after_display":"13,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider"},{"id":3372236,"accession":"0001181431-12-000394","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-000394","line_url":"/filing/0001181431-12-000394#line-3","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; POWELL MICHAEL; Sofinnova Management VI, L.L.C.; Sofinnova Venture Partners VI GmbH & Co. KG; SOFINNOVA VENTURE PARTNERS VI L P; Buatois Eric; Azan Alain","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20630.0,"shares_display":"20,630","price_per_share":6.225,"price_display":"6.22","price_state":"stated","total_value":128421.75,"total_display":"128,421.75","total_whole":"128,422","shares_owned_after":3298684.0,"shares_owned_after_display":"3,298,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-03","scope":"insider"},{"id":3372232,"accession":"0001181431-12-000394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-000394","line_url":"/filing/0001181431-12-000394#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; POWELL MICHAEL; Sofinnova Management VI, L.L.C.; Sofinnova Venture Partners VI GmbH & Co. KG; SOFINNOVA VENTURE PARTNERS VI L P; Buatois Eric; Azan Alain","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4090.0,"shares_display":"4,090","price_per_share":6.225,"price_display":"6.22","price_state":"stated","total_value":25460.25,"total_display":"25,460.25","total_whole":"25,460","shares_owned_after":653550.0,"shares_owned_after_display":"653,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-03","scope":"insider"},{"id":3372227,"accession":"0001181431-12-000394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-000394","line_url":"/filing/0001181431-12-000394#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Affiliates VI LP; POWELL MICHAEL; Sofinnova Management VI, L.L.C.; Sofinnova Venture Partners VI GmbH & Co. KG; SOFINNOVA VENTURE PARTNERS VI L P; Buatois Eric; Azan Alain","owner_display_name":"Sofinnova Venture Affiliates VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":6.225,"price_display":"6.22","price_state":"stated","total_value":1743.0,"total_display":"1,743.00","total_whole":"1,743","shares_owned_after":44969.0,"shares_owned_after_display":"44,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-03","scope":"insider"},{"id":9094638,"accession":"0001181431-11-061935","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-6","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20630.0,"shares_display":"20,630","price_per_share":6.2242,"price_display":"6.22","price_state":"stated","total_value":128405.246,"total_display":"128,405.25","total_whole":"128,405","shares_owned_after":3319314.0,"shares_owned_after_display":"3,319,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9094637,"accession":"0001181431-11-061935","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4090.0,"shares_display":"4,090","price_per_share":6.2242,"price_display":"6.22","price_state":"stated","total_value":25456.978,"total_display":"25,456.98","total_whole":"25,457","shares_owned_after":657640.0,"shares_owned_after_display":"657,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9094636,"accession":"0001181431-11-061935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-4","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":6.2242,"price_display":"6.22","price_state":"stated","total_value":1742.776,"total_display":"1,742.78","total_whole":"1,743","shares_owned_after":45249.0,"shares_owned_after_display":"45,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9094635,"accession":"0001181431-11-061935","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-3","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20630.0,"shares_display":"20,630","price_per_share":6.5108,"price_display":"6.51","price_state":"stated","total_value":134317.804,"total_display":"134,317.80","total_whole":"134,318","shares_owned_after":3339944.0,"shares_owned_after_display":"3,339,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"},{"id":9094634,"accession":"0001181431-11-061935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4090.0,"shares_display":"4,090","price_per_share":6.5108,"price_display":"6.51","price_state":"stated","total_value":26629.172,"total_display":"26,629.17","total_whole":"26,629","shares_owned_after":661730.0,"shares_owned_after_display":"661,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"},{"id":9094633,"accession":"0001181431-11-061935","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-061935","line_url":"/filing/0001181431-11-061935#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Buatois Eric; POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; SOFINNOVA VENTURE PARTNERS VI L P; Sofinnova Management VI, L.L.C.","owner_display_name":"Sofinnova Venture Partners VI GmbH & Co. KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":6.5108,"price_display":"6.51","price_state":"stated","total_value":1823.024,"total_display":"1,823.02","total_whole":"1,823","shares_owned_after":45529.0,"shares_owned_after_display":"45,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS INC","url":"/issuer/0001267813","role":"Ten percent owner","n_filings":2,"first_seen":"2014-08-07","last_seen":"2016-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Ten percent owner","n_filings":1,"first_seen":"2013-07-17","last_seen":"2013-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Ten percent owner","n_filings":2,"first_seen":"2011-12-23","last_seen":"2012-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001397188","retrieved_at":"2026-08-22T04:59:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}